drugset / Trial / NCT03586323

Awake Fiber Optic Intubation (AFOI) and Laryngeal Nervous Block

NCT03586323 ↗

Unknown 40 enrolled University of Roma La Sapienza
RandomizedParallel-groupDouble-blindTreatment

Summary

Oncologic laryngeal surgery is a challenge for anesthesiologists and awake fiberoptic intubation (AFOI) is mandatory to manage difficult airways and prevent the Can't Intubate Can't Oxigenate (CICO). Laryngospasm and oversedation are dangerous complication often life-threatening in this kind of patient. Superior laryngeal nerve block (SLNB) could be an alternative technique useful to reduce risks and to improve patient comfort. Aim of this study is to assess the procedural comfort of the SLNB during AFOI, in a population of patients suffering from severe airways obstruction undergoing pharyngeal-laryngeal surgery. 40 patients will be randomized in two groups(20 for each group) and will be treated with continuous infusion of remifentanil, topic anesthesia of the base of the tongue and intercricoid block. In group A will be associated the SLNB; placebo will be administered in group B.

Timeline

Start
2018-04-15
Primary completion
2018-07-24
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 % Other
Subject Lidocaine Other / unclassified 4 ml Other

Indications

No indication recorded.